Cargando…
A rare case of cefepime-induced cholestatic liver injury
Cefepime is widely used in the hospital setting, and only a few studies have reported neurotoxicity and nephrotoxicity as side effects of this drug. Herein, we present a 93-year-old man who exhibited features of cholestatic hepatitis including elevated blood transaminases and direct-form predominant...
Autores principales: | Liao, Pei-Fei, Wu, Yao-Kuang, Huang, Kuo-Liang, Chen, Hsin-Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6450155/ https://www.ncbi.nlm.nih.gov/pubmed/31007494 http://dx.doi.org/10.4103/tcmj.tcmj_151_18 |
Ejemplares similares
-
Cefepime: Cefepime-induced encephalopathy: case report
Publicado: (2022) -
Kratom-Induced Cholestatic Liver Injury and Its Conservative Management
por: Fernandes, Christopher T., et al.
Publicado: (2019) -
Dabigatran etexilate: Cholestatic liver injury: case report
Publicado: (2021) -
Chronic Cholestatic Liver Injury Attributable to Vedolizumab
por: Stine, Jonathan G., et al.
Publicado: (2016) -
Cholestatic Liver Injury Induced by Pembrolizumab in a Patient with Lung Adenocarcinoma
por: Kurokawa, Kana, et al.
Publicado: (2019)